Welcome to our dedicated page for Columbia EM Core ex-China ETF news (Ticker: XCEM), a resource for investors and traders seeking the latest updates and insights on Columbia EM Core ex-China ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Columbia EM Core ex-China ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Columbia EM Core ex-China ETF's position in the market.
Columbia Threadneedle Investments celebrates the 10th anniversary of its Columbia EM Core ex-China ETF (XCEM), the first broad-based emerging markets ETF to exclude China exposure. Launched in 2015, the four-star Morningstar-rated fund has accumulated over $1.1 billion in client assets.
The ETF has demonstrated strong performance, ranking in the top 16% of Morningstar's U.S. Fund Diversified Emerging Markets category for the 5-year period. XCEM tracks the Beta Thematic® Emerging Markets Ex-China Index, covering up to 700 emerging markets companies. With 332 holdings and a competitive 0.16% expense ratio, XCEM offers investors a balanced approach to emerging markets investing while controlling exposure to China-related risks.
FAQ
What is the current stock price of Columbia EM Core ex-China ETF (XCEM)?
